Testing effectiveness (Phase 2)Study completedNCT02423577
What this trial is testing
Safety and Protective Efficacy of FF-3 Dry Powder in Healthy Subjects Infected With Influenza Challenge Strain
Who this might be right for
Influenza
Autoimmune Technologies, LLC 79